NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 7.13% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 5.00% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.67% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.05% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.85% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.59% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.03% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.84% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.83% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.76% |
| LFST | Lifestance Health Group Inc | Healthcare | Medical Care Facilities | 2.73% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.57% |
| AGL | agilon health Inc | Healthcare | Medical Care Facilities | 2.42% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.30% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.24% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.21% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.09% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.09% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.98% |